ICR and EMWA Collaborate for Second Joint Symposium
ICR and EMWA Collaborate for Second Joint Symposium
14 January 2009-The Institute of Clinical Research (ICR) is teaming up with the European Medical Writers Association (EMWA) in the New Year for their second joint symposium.
The seminar, entitled: Writing Protocols-collaboration and compromise or conflict and confusion?, takes place on 24 February at Novotel London Paddington and will bring together professionals involved in protocol writing, providing a forum to discuss and debate different points of view.
The day-long symposium will feature a series of thought-provoking presentations led by industry professionals and will close with a panel discussion and question and answer session. The programme is split into a morning and afternoon session, chaired by freelance medical writer Wendy Kingdom and Adam Jacobs from Dianthus Medical Limited.
Dr John Hooper, chief executive of ICR, commented: “This is our second joint symposium with EMWA following the highly-successful inaugural event in 2008.
“We are expecting that our diverse range of presenters and panellists representing the different areas of clinical research from medical writing and project management to ethics committees and investigative sites will spark fascinating debates and discussions.”
Several presentations will take place throughout the day covering topics such as the trials and tribulations of recruiting patients and the details and diplomacy of medical writing for protocols.
A month after the joint ICR and EMWA symposium will see the ICR hold its 30th anniversary Spring Conference and Exhibition. Taking place at the ICC in Birmingham on 17th and 18th March the conference will focus on Essential Updates and Lively Debates.
For further information about the symposium and to register as a delegate, please log onto the website at www.icr-global.org/community.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
